6YG9

CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN (HSA) IN COMPLEX WITH GN-07.

6YG9 の概要

• エントリーDOI: 10.2210/pdb6yg9/pdb
• 関連するPDBエントリー: 6yau
• 分子名称: Serum albumin, MYRISTIC ACID, 20-[[(2~{S})-5-[2-[2-[2-[2-[2-[2-(diethylamino)-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-1-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-20-oxidanylidene-icosanoic acid, ... (4 entities in total)
• 機能のキーワード: drug transport, fatty acid binding, liver imaging, nash, human serum albumin, transport protein
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 68758.51

構造登録者

Schreuder, H.A.,Liesum, A. (登録日: 2020-03-27, 公開日: 2021-01-13, 最終更新日: 2024-10-09)

主引用文献

Mishra, A.,Castaneda, T.R.,Bader, E.,Elshorst, B.,Cummings, S.,Scherer, P.,Bangari, D.S.,Loewe, C.,Schreuder, H.,Poverlein, C.,Helms, M.,Jones, S.,Zech, G.,Licher, T.,Wagner, M.,Schudok, M.,de Hoop, M.,Plowright, A.T.,Atzrodt, J.,Kannt, A.,Laitinen, I.,Derdau, V.
Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis.
Adv Sci, 7:2002997-2002997, 2020

PubMed Abstract: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease that can lead to irreversible liver cirrhosis and cancer. Early diagnosis of NASH is vital to detect disease before it becomes life-threatening, yet noninvasively differentiating NASH from simple steatosis is challenging. Herein, bifunctional probes have been developed that target the hepatocyte-specific asialoglycoprotein receptor (ASGPR), the expression of which decreases during NASH progression. The results show that the probes allow longitudinal, noninvasive monitoring of ASGPR levels by positron emission tomography in the newly developed rat model of NASH. The probes open new possibilities for research into early diagnosis of NASH and development of drugs to slow or reverse its progression.

PubMed: 33344141
DOI: 10.1002/advs.202002997

実験手法

X-RAY DIFFRACTION (1.89 Å)